BIORA THERAPEUTICS, INC. Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Biora Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • Biora Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$12.3M, a 76.4% increase year-over-year.
  • Biora Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$15.4M, a 71.6% increase year-over-year.
  • Biora Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$65.5M, a 2602% decline from 2022.
  • Biora Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $2.62M, a 56.3% decline from 2021.
  • Biora Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $5.99M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$65.5M -$68.1M -2602% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $2.62M -$3.37M -56.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $5.99M +$31.1M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$25.1M -$25.7M -4462% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $575K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.